Johnson & Johnson COVID-19 vaccine pause signal ‘security system is working for you,’ Murthy says

Whereas some have questioned whether or not the Johnson & Johnson COVID-19 vaccine pause will contribute to shot hesitancy and even flip some away from in search of a jab, the U.S. Surgeon Normal mentioned Friday that it needs to be seen as an indication that the “security system is working for you.” Dr. Vivek Murthy, who was partaking within the White Home’s COVID-19 briefing on Friday, mentioned that officers have been working diligently and transparently for the “folks to know what we all know.”

“Our message has been constant that primary this pause is in regards to the Johnson and Johnson vaccine,” Murthy mentioned. “If folks have appointments to get the Pfizer or Moderna vaccine, we wish them to maintain these appointments, we now have nice religion within the effectiveness of these vaccines they usually have very sturdy security profiles.”

Second, he added, that for the hundreds of thousands who’ve already acquired the Johnson & Johnson vaccine, the general danger of growing the uncommon, extreme clot seen in six recipients to this point, is minimal.


“I do know that folks have questions on this given the instances they heard about, however remember that greater than 7 million folks have acquired the Johnson & Johnson vaccine, and we really feel fairly assured that the huge, overwhelming majority of them are simply going to be superb,” he mentioned. “Third, simply keep in mind, that is your security system working for you, what you’re seeing proper now. A sign got here up, the FDA and CDC jumped on it and determined to analyze completely and that’s what’s taking place. That if something, I imagine, ought to enhance folks’s confidence that they’re being instructed what’s occurring and that any indicators are being investigated.”

Dr. Rochelle Walensky, CDC director, additionally addressed the Advisory Committee on Immunization Follow’s choice to increase the pause with the intention to acquire extra knowledge and proceed weighing the risk-benefit of the vaccine. Walensky mentioned that the company “acknowledges the essential significance of transferring rapidly” in the course of the investigation.


“What I might say to the American folks is what we discovered is admittedly extraordinarily uncommon instances by way of our vaccine security monitoring system,” Walensky mentioned, including that the following ACIP assembly slated for subsequent Friday can be made public for transparency.

She additionally urged Individuals to proceed rolling up their sleeves to obtain both the Moderna or Pfizer jab because the nation sees a rise in each day case counts, hospitalizations and deaths. Walensky warned that the rising prevalence of variants, particularly the U.Ok. B.1.1.7 pressure, which now accounts for upwards of 44% of U.S. instances, threatens to undo the progress made to this point. 


She mentioned the latest drive in new instances is because of relaxed mitigation measures and that the diseases “threaten to overwhelm our well being care system once more in elements of the nation.”

Earlier within the briefing, Andy Slavitt mentioned $1.7 billion made out there by way of the American Rescue Plan would go towards genomic sequencing for the detection and surveillance of rising variants. 

Leave a Reply

Your email address will not be published. Required fields are marked *